PUBLISHER: TechNavio | PRODUCT CODE: 1915410
PUBLISHER: TechNavio | PRODUCT CODE: 1915410
Global Porcine Vaccine Market 2025-2029
The global porcine vaccine market is forecasted to grow by USD 763.3 mn during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the global porcine vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of porcine diseases, increase in research and development expenditure for development of porcine vaccines, growing animal healthcare expenditure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 6.1% |
| CAGR | 6.4% |
| Incremental Value | $763.3 mn |
Technavio's global porcine vaccine market is segmented as below:
By Product
- Intravenous
- Intramuscular
By Distribution Channel
- Veterinary clinics
- Veterinary hospitals
- Pharmacies and drug stores
- Others
By Route Of Administration
- Parenteral
- Oral
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the growing demand for pork and gelatin as one of the prime reasons driving the global porcine vaccine market growth during the next few years. Also, increasing government initiatives for funding animal husbandry sector and strategic initiatives by market vendors will lead to sizable demand in the market.
The report on the global porcine vaccine market covers the following areas:
- Global porcine vaccine market sizing
- Global porcine vaccine market forecast
- Global porcine vaccine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global porcine vaccine market vendors that include AdvaCare Pharma, Bimeda Holdings Ltd., Bioveta AS, Boehringer Ingelheim GmbH, Ceva Sante Animale, Creative Biolabs, Elanco Animal Health Inc., Endovac Animal Health, FATRO SpA, Formosa Biomedical Inc., HIPRA SA, IDT Biologika GmbH, Indian Immunologicals Ltd., Merck and Co. Inc., Phibro Animal Health Corp., Shandong Sinder Technology Co. Ltd., Vaxxinova International BV, Vetoquinol SA, Virbac Group, Zoetis Inc.. Also, the global porcine vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Porcine Vaccine Market 2019 - 2023
- Historic Market Size - Data Table on Global Porcine Vaccine Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 The AI impact on Global Porcine Vaccine Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Intravenous - Market size and forecast 2024-2029
- 8.4 Intramuscular - Market size and forecast 2024-2029
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel
- 9.1 Market segments
- 9.2 Comparison by Distribution Channel
- 9.3 Veterinary clinics - Market size and forecast 2024-2029
- 9.4 Veterinary hospitals - Market size and forecast 2024-2029
- 9.5 Pharmacies and drug stores - Market size and forecast 2024-2029
- 9.6 Others - Market size and forecast 2024-2029
- 9.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
- 10.1 Market segments
- 10.2 Comparison by Route of Administration
- 10.3 Parenteral - Market size and forecast 2024-2029
- 10.4 Oral - Market size and forecast 2024-2029
- 10.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
- 12.4 Europe - Market size and forecast 2024-2029
- 12.4.1 Germany - Market size and forecast 2024-2029
- 12.4.2 UK - Market size and forecast 2024-2029
- 12.4.3 France - Market size and forecast 2024-2029
- 12.4.4 Italy - Market size and forecast 2024-2029
- 12.4.5 The Netherlands - Market size and forecast 2024-2029
- 12.4.6 Spain - Market size and forecast 2024-2029
- 12.5 Asia - Market size and forecast 2024-2029
- 12.5.1 China - Market size and forecast 2024-2029
- 12.5.2 Japan - Market size and forecast 2024-2029
- 12.5.3 India - Market size and forecast 2024-2029
- 12.5.4 South Korea - Market size and forecast 2024-2029
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Australia - Market size and forecast 2024-2029
- 12.6.2 Brazil - Market size and forecast 2024-2029
- 12.6.3 Argentina - Market size and forecast 2024-2029
- 12.6.4 Colombia - Market size and forecast 2024-2029
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.6 UAE - Market size and forecast 2024-2029
- 12.6.7 South Africa - Market size and forecast 2024-2029
- 12.6.8 Israel - Market size and forecast 2024-2029
- 12.6.9 Turkey - Market size and forecast 2024-2029
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of porcine diseases
- Increase in research and development expenditure for development of porcine vaccines
- Growing animal healthcare expenditure
- 13.2 Market challenges
- Lack of trained veterinary doctors
- Chance of reverse reaction from vaccines
- Stringent government regulations
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Growing demand for pork and gelatin
- Increasing government initiatives for funding animal husbandry sector
- Strategic initiatives by market vendors
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 AdvaCare Pharma
- AdvaCare Pharma - Overview
- AdvaCare Pharma - Product / Service
- AdvaCare Pharma - Key offerings
- SWOT
- 15.5 Bimeda Holdings Ltd.
- Bimeda Holdings Ltd. - Overview
- Bimeda Holdings Ltd. - Product / Service
- Bimeda Holdings Ltd. - Key offerings
- SWOT
- 15.6 Bioveta AS
- Bioveta AS - Overview
- Bioveta AS - Product / Service
- Bioveta AS - Key offerings
- SWOT
- 15.7 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key news
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- 15.8 Ceva Sante Animale
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product / Service
- Ceva Sante Animale - Key offerings
- SWOT
- 15.9 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
- SWOT
- 15.10 FATRO SpA
- FATRO SpA - Overview
- FATRO SpA - Product / Service
- FATRO SpA - Key offerings
- SWOT
- 15.11 Formosa Biomedical Inc.
- Formosa Biomedical Inc. - Overview
- Formosa Biomedical Inc. - Product / Service
- Formosa Biomedical Inc. - Key offerings
- SWOT
- 15.12 HIPRA SA
- HIPRA SA - Overview
- HIPRA SA - Product / Service
- HIPRA SA - Key offerings
- SWOT
- 15.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
- 15.14 Phibro Animal Health Corp.
- Phibro Animal Health Corp. - Overview
- Phibro Animal Health Corp. - Business segments
- Phibro Animal Health Corp. - Key offerings
- Phibro Animal Health Corp. - Segment focus
- SWOT
- 15.15 Shandong Sinder Technology Co. Ltd.
- Shandong Sinder Technology Co. Ltd. - Overview
- Shandong Sinder Technology Co. Ltd. - Product / Service
- Shandong Sinder Technology Co. Ltd. - Key offerings
- SWOT
- 15.16 Vaxxinova International BV
- Vaxxinova International BV - Overview
- Vaxxinova International BV - Product / Service
- Vaxxinova International BV - Key offerings
- SWOT
- 15.17 Virbac Group
- Virbac Group - Overview
- Virbac Group - Business segments
- Virbac Group - Key offerings
- Virbac Group - Segment focus
- SWOT
- 15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key news
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
